Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MRNA)

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Accesswire 1 day ago

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress

Accesswire 8 days ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine

Accesswire 9 days ago

Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign

Accesswire 11 days ago

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024

Accesswire April 17, 2024

Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

Accesswire April 3, 2024

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials

Accesswire March 27, 2024

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

Accesswire March 26, 2024

Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024

Accesswire February 29, 2024
View More News ››

Opinion & Analysis (NDAQ:MRNA)

Memphasys, Moderna, Paion - Investments in solutions with potential

Stockhouse Editorial June 2, 2020

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data

Streetwise Reports May 19, 2020

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

Streetwise Reports April 23, 2020

U.S.-Based Biotech 'Growing into a Giant with AI'

Streetwise Reports March 9, 2020

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study

Streetwise Reports February 26, 2020

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Streetwise Reports September 13, 2019
View More Opinion ››

Bullboard Posts (NDAQ:MRNA)

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For

Just In: $MRNA Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars...
whytestocks - 1 day ago

Moderna (MRNA) Q1 2024 Earnings Call Transcript

NEWS: $MRNA Moderna (MRNA) Q1 2024 Earnings Call Transcript2024-05-02 12:30:13 ET Image source: The Motley Fool. Moderna (NASDAQ: MRNA...
whytestocks - 1 day ago

Should You Buy Moderna Before May 12?

Just In: $MRNA Should You Buy Moderna Before May 12?2024-04-26 04:50:00 ET Moderna (NASDAQ: MRNA) stock soared earlier in the pandemic...
whytestocks - 7 days ago

Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Tradi

NEWS: $MRNA Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage GainModerna, Inc. (NASDAQ: MRNA) is one...
whytestocks - April 9, 2024

Reduce Recommendation Issued On MRNA By HSBC

Just In: $MRNA Reduce Recommendation Issued On MRNA By HSBC2024-02-26 09:15:03 ET HSBC analyst issues REDUCE recommendation for MRNA on...
whytestocks - February 26, 2024

Moderna Stock Is Moving Higher: What's Going On? | Benzinga

JUST IN: $MRNA Moderna Stock Is Moving Higher: What's Going On? | BenzingaModerna@Inc (NASDAQ: MRNA) shares are trading higher...
whytestocks - January 2, 2024
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc. is a Canada-based exploration company engaged in the discovery and development of mineral projects in ...
View More »